The TRIM21-FOXD1-BCL-2 axis underlies hyperglycaemic cell death and diabetic tissue damage.
Wenwen ChengCifeng CaiYifan XuXueqi XiaoTiantian ShiYueling LiaoXiaoyi WangShasha ChenMeiliang ZhouZhiyong LiaoPublished in: Cell death & disease (2023)
Chronic hyperglycaemia is a devastating factor that causes diabetes-induced damage to the retina and kidney. However, the precise mechanism by which hyperglycaemia drives apoptotic cell death is incompletely known. Herein, we found that FOXD1, a FOX family transcription factor specifically expressed in the retina and kidney, regulated the transcription of BCL-2, a master regulator of cell survival. Intriguingly, the protein level of FOXD1, which responded negatively to hyperglycaemic conditions, was controlled by the TRIM21-mediated K48-linked polyubiquitination and subsequent proteasomal degradation. The TRIM21-FOXD1-BCL-2 signalling axis was notably active during diabetes-induced damage to murine retinal and renal tissues. Furthermore, we found that tartary buckwheat flavonoids effectively reversed the downregulation of FOXD1 protein expression and thus restored BCL-2 expression and facilitated the survival of retinal and renal tissues. In summary, we identified a transcription factor responsible for BCL-2 expression, a signalling axis (TRM21-FOXD1-BCL-2) underlying hyperglycaemia-triggered apoptosis, and a potential treatment for deleterious diabetic complications.
Keyphrases
- cell death
- transcription factor
- type diabetes
- oxidative stress
- cell cycle arrest
- diabetic retinopathy
- poor prognosis
- cardiovascular disease
- optical coherence tomography
- diabetic rats
- optic nerve
- high glucose
- binding protein
- glycemic control
- drug induced
- dna binding
- signaling pathway
- cell proliferation
- metabolic syndrome
- endoplasmic reticulum stress
- wound healing
- risk assessment
- amino acid
- combination therapy
- weight loss